US equities |
MU $1,040.39 ▼-4.38% NVDA $230.81 ▼-2.80% SNDK $1,607.82 ▼-5.00% AMD $616.66 ▼-4.52% INTC $105.89 ▼-6.39% SPCX $161.87 ▼-3.42% PLTR $196.41 ▲+1.18% META $714.97 ▼-0.88%
FinancialContent

Articles published by Ensysce Biosciences, Inc.

News headline image
Ensysce Biosciences Announces Positive Bioequivalence (BE) Study Data of Novel "TAAP" Opioid PF614 and Provides Timing of Corporate Update Call
From Ensysce Biosciences, Inc.
Via AccessWire
Tickers ENSC ENSCW
News headline image
Ensysce Biosciences Announces Initial Patients Dosed of First Human Abuse Potential Study
From Ensysce Biosciences, Inc.
Via AccessWire
Tickers ENSC ENSCW
News headline image
Ensysce Biosciences Secures $8 Million Convertible Note Financing
From Ensysce Biosciences, Inc.
Via AccessWire
Tickers ENSC ENSCW
News headline image
Ensysce Biosciences Receives Notice of Award for 4th Year of Funding for Its Multi-Pill Abuse Resistance (MPAR(TM)) Platform
From Ensysce Biosciences, Inc.
Via AccessWire
Tickers ENSC ENSCW
News headline image
Ensysce Biosciences Reminds Shareholders to Vote At Upcoming 2022 Virtual Annual Shareholder Meeting
From Ensysce Biosciences, Inc.
Via AccessWire
Topics Death Intellectual Property
Tickers ENSC ENSCW
News headline image
Ensysce Biosciences Announces Initiation of First Human Abuse Potential Study
From Ensysce Biosciences, Inc.
Via AccessWire
Tickers ENSC ENSCW
News headline image
Ensysce Biosciences Provides Business Update and Reports First Quarter 2022 Financial Results
From Ensysce Biosciences, Inc.
Via AccessWire
Tickers ENSC ENSCW
News headline image
Ensysce Biosciences Releases 2021 Annual Shareholder Letter
From Ensysce Biosciences, Inc.
Via AccessWire
Topics Death Intellectual Property Regulatory Compliance
Tickers ENSC ENSCW
News headline image
Dr. Lynn Kirkpatrick, Invited Speaker at SMi 22nd Annual Pain Therapeutics Conference in London UK
From Ensysce Biosciences, Inc.
Via AccessWire
Tickers ENSC ENSCW
News headline image
Ensysce Biosciences Announces Appointment of Dr. Nily Osman as Chief Medical Officer
From Ensysce Biosciences, Inc.
Via AccessWire
Tickers ENSC ENSCW
News headline image
Ensysce Biosciences Announces Fourth Quarter and Full Year 2021 Earnings Release Date and Timing of Corporate Update Call
From Ensysce Biosciences, Inc.
Via AccessWire
Tickers ENSC ENSCW
News headline image
Ensysce Biosciences Sets September 2021 Conference Schedule
From Ensysce Biosciences, Inc.
Via AccessWire
Topics Death Intellectual Property Regulatory Compliance
Tickers ENSC ENSCW